MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma

Objective To explore the potential value of expert-identified CT and MRI imaging features in predicting the MGMT promoter methylation status in glioma. Methods A retrospective analysis was conducted in 188 patients in The First Medical Center of Chinese PLA General Hospital from January 2019 to Dec...

Full description

Saved in:
Bibliographic Details
Main Authors: ZHANG Zhi-zhong, YOU Na, LIU Ming-hang, LI Ze, SUN Guo-chen, ZHAO Kai
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2025-07-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/3061
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043868776497152
author ZHANG Zhi-zhong
YOU Na
LIU Ming-hang
LI Ze
SUN Guo-chen
ZHAO Kai
author_facet ZHANG Zhi-zhong
YOU Na
LIU Ming-hang
LI Ze
SUN Guo-chen
ZHAO Kai
author_sort ZHANG Zhi-zhong
collection DOAJ
description Objective To explore the potential value of expert-identified CT and MRI imaging features in predicting the MGMT promoter methylation status in glioma. Methods A retrospective analysis was conducted in 188 patients in The First Medical Center of Chinese PLA General Hospital from January 2019 to December 2020 with pathologically confirmed glioma. Imaging features were extracted, including calcification, clear lesion margins, peritumoral edema, T2WI/T2-FLAIR mismatch, cortical involvement, subventricular zone involvement, insular involvement, homogeneous signal on T2WI, and enhanced lesions. Pyrosequencing was used to detect the MGMT promoter methylation status. Univariate and multivariate Logistic regression analyses were used to find the imaging feature factors that affect the MGMT promoter methylation status. Then, by plotting the receiver operating characteristic (ROC) curve, verify the predictive efficacy of the imaging features. For the prediction task, further train and test 4 machine learning (ML) models, namely Logistic regression (LR), support vector machine (SVM), random forest (RF), and gradient boosting (GB). Results Logistic regression analysis showed that homogeneous signal on T2WI (OR = 2.843, 95%CI: 1.055-7.658; P = 0.039) and enhanced lesions (OR = 0.146, 95%CI: 0.069-0.308; P = 0.000) were imaging feature factors affecting the MGMT promoter methylation status. The comprehensive parameters combining both had higher prediction ability compared with homogeneous signal on T2WI (Z = 3.961, P = 0.000) and enhanced lesions (Z = 2.233, P = 0.026). The prediction accuracies rates of LR, SVM, RF and GB models were 0.84, 0.76, 0.68 and 0.76, respectively. However, there were no statistically significant differences in prediction efficacy when comparing the models pairwise (P > 0.05, for all). Conclusions Imaging features based on preoperative CT and MRI show promise for non-invasive prediction of MGMT promoter methylation status in glioma.
format Article
id doaj-art-df98a2d315714e8f9a3e403821faa464
institution DOAJ
issn 1672-6731
language English
publishDate 2025-07-01
publisher Tianjin Huanhu Hospital
record_format Article
series Chinese Journal of Contemporary Neurology and Neurosurgery
spelling doaj-art-df98a2d315714e8f9a3e403821faa4642025-08-20T02:55:06ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312025-07-0125759560110.3969/j.issn.1672⁃6731.2025.07.005MRI feature-based discrimination model for prediction of MGMT promoter methylation status in gliomaZHANG Zhi-zhong0YOU Na1LIU Ming-hang2LI Ze3SUN Guo-chen4ZHAO Kai5Department of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaDepartment of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaDepartment of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaDepartment of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaDepartment of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaDepartment of Neurosurgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, ChinaObjective To explore the potential value of expert-identified CT and MRI imaging features in predicting the MGMT promoter methylation status in glioma. Methods A retrospective analysis was conducted in 188 patients in The First Medical Center of Chinese PLA General Hospital from January 2019 to December 2020 with pathologically confirmed glioma. Imaging features were extracted, including calcification, clear lesion margins, peritumoral edema, T2WI/T2-FLAIR mismatch, cortical involvement, subventricular zone involvement, insular involvement, homogeneous signal on T2WI, and enhanced lesions. Pyrosequencing was used to detect the MGMT promoter methylation status. Univariate and multivariate Logistic regression analyses were used to find the imaging feature factors that affect the MGMT promoter methylation status. Then, by plotting the receiver operating characteristic (ROC) curve, verify the predictive efficacy of the imaging features. For the prediction task, further train and test 4 machine learning (ML) models, namely Logistic regression (LR), support vector machine (SVM), random forest (RF), and gradient boosting (GB). Results Logistic regression analysis showed that homogeneous signal on T2WI (OR = 2.843, 95%CI: 1.055-7.658; P = 0.039) and enhanced lesions (OR = 0.146, 95%CI: 0.069-0.308; P = 0.000) were imaging feature factors affecting the MGMT promoter methylation status. The comprehensive parameters combining both had higher prediction ability compared with homogeneous signal on T2WI (Z = 3.961, P = 0.000) and enhanced lesions (Z = 2.233, P = 0.026). The prediction accuracies rates of LR, SVM, RF and GB models were 0.84, 0.76, 0.68 and 0.76, respectively. However, there were no statistically significant differences in prediction efficacy when comparing the models pairwise (P > 0.05, for all). Conclusions Imaging features based on preoperative CT and MRI show promise for non-invasive prediction of MGMT promoter methylation status in glioma.http://www.cjcnn.org/index.php/cjcnn/article/view/3061gliomamagnetic resonance imagingo(6)-methylguanine-dna methyltransferaselogistic modelsmachine learning
spellingShingle ZHANG Zhi-zhong
YOU Na
LIU Ming-hang
LI Ze
SUN Guo-chen
ZHAO Kai
MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
Chinese Journal of Contemporary Neurology and Neurosurgery
glioma
magnetic resonance imaging
o(6)-methylguanine-dna methyltransferase
logistic models
machine learning
title MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
title_full MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
title_fullStr MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
title_full_unstemmed MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
title_short MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
title_sort mri feature based discrimination model for prediction of mgmt promoter methylation status in glioma
topic glioma
magnetic resonance imaging
o(6)-methylguanine-dna methyltransferase
logistic models
machine learning
url http://www.cjcnn.org/index.php/cjcnn/article/view/3061
work_keys_str_mv AT zhangzhizhong mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma
AT youna mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma
AT liuminghang mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma
AT lize mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma
AT sunguochen mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma
AT zhaokai mrifeaturebaseddiscriminationmodelforpredictionofmgmtpromotermethylationstatusinglioma